Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

EFFECT - Notice of Effectiveness

Form Type: EFFECT

Filing Date: 2011-02-28

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2011-02-28

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2011-02-28

View Filing

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]

Form Type: 10-K/A

Filing Date: 2011-02-25

View Filing

POS AM - Post-Effective amendments for registration statement

Form Type: POS AM

Filing Date: 2011-02-16

View Filing

POS AM - Post-Effective amendments for registration statement

Form Type: POS AM

Filing Date: 2011-02-16

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2011-02-14

View Filing

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form Type: 10-K

Filing Date: 2011-01-31

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2011-01-05

View Filing

424B3 - Prospectus [Rule 424(b)(3)]

Form Type: 424B3

Filing Date: 2011-01-05

View Filing